EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BRAF Mutation Status and Histopathological Differentiation Patterns in Non–Small Cell Lung Cancer: A Tertiary Referral Center Study in Indonesia

Lela Khaibirunna A.P, Noni Novisari Soeroso, Desfrina Kasuma, Putri Eyanoer

Journal of Society Medicine · 31.05.2026 · 5 (5) · 181-187

DOI: 10.71197/jsocmed.v5i5.281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Society Medicine, online erschienen am 31.05.2026. Verfasst von Lela Khaibirunna A.P und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Non-small cell lung cancer (NSCLC) is the most common subtype of lung cancer and a major cause of cancer-related mortality worldwide. BRAF mutations have emerged as clinically relevant molecular alterations associated with tumor behavior and targeted therapy responses. However, evidence regarding their relationship with histopathological differentiation remains limited, particularly in the Indonesian population. This study aimed to evaluate the association between BRAF mutation status and histopathological differentiation in patients with NSCLC at a tertiary referral center in Indonesia.

Methods

This retrospective cross-sectional study included patients diagnosed with NSCLC at a tertiary hospital in Medan, Indonesia. Clinical and demographic data were obtained from patients’ medical records. Histopathological differentiation was classified as well-, moderately, or poorly differentiated. BRAF mutation analysis was performed using real-time polymerase chain reaction on formalin-fixed paraffin-embedded tissue samples. Statistical analyses were performed to determine the association between BRAF mutation status and histopathological differentiation.

Results

Most patients were men (76.7%), aged >40 years, and had a history of smoking (74.2%). Adenocarcinoma was the predominant histological subtype (75%), and most patients were diagnosed at stage IVA (60%). BRAF mutations were identified in 3.3% of the patients. Histopathological evaluation revealed that 20.8%, 37.5%, and 41.7% of the tumors were well-, moderately-, and poorly differentiated, respectively. A significant association was observed between BRAF mutation status and histopathological differentiation (P = 0.001), with mutations being more frequently detected in poorly differentiated tumors.

Conclusion

BRAF mutations were identified in a small proportion of NSCLC patients and were significantly associated with poor histopathological differentiation, suggesting a potential role in aggressive tumor biology.

Zitieren

APA

A.P, L. K., Soeroso, N. N., Kasuma, D., & Eyanoer, P. (2026). BRAF Mutation Status and Histopathological Differentiation Patterns in Non–Small Cell Lung Cancer: A Tertiary Referral Center Study in Indonesia. Journal of Society Medicine, 5(5), 181-187. https://doi.org/10.71197/jsocmed.v5i5.281

Vancouver

A.P LK, Soeroso NN, Kasuma D, Eyanoer P. BRAF Mutation Status and Histopathological Differentiation Patterns in Non–Small Cell Lung Cancer: A Tertiary Referral Center Study in Indonesia. Journal of Society Medicine. 2026;5(5):181-187. doi:10.71197/jsocmed.v5i5.281

BibTeX
@article{AP2026,
  author = {A.P, Lela Khaibirunna and Soeroso, Noni Novisari and Kasuma, Desfrina and Eyanoer, Putri},
  title = {BRAF Mutation Status and Histopathological Differentiation Patterns in Non–Small Cell Lung Cancer: A Tertiary Referral Center Study in Indonesia},
  journal = {Journal of Society Medicine},
  year = {2026},
  volume = {5},
  number = {5},
  pages = {181--187},
  doi = {10.71197/jsocmed.v5i5.281}
}
Kostenlos starten →